Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
OtoNexus has developed a unique patented miniaturized ultrasound transducer that can be placed in the tip of a speculum. The transducer scans the middle ear for effusion behind the tympanic membrane and characterizes the type of fluid present. It provides a quantitative score to the physician so they can determine if an antibiotic prescription is necessary. In effect, the company’s ultrasound otoscope provides data in seconds for pediatricians to instantly know the best treatment for middle ear infections.![]()
In our product development research, a focus group survey of 60 physicians got 100 percent positive results - every single doctor said they would buy the product as described
Share this Article:
Tweet
|
Company
OtoNexus Medical Technologies
Headquarters
Seattle, WA
Management
Caitlin Cameron, CEO
Description
OtoNexus has developed an easy-to-use device that provides the right diagnostic data needed by physicians to determine clearly when an antibiotic is appropriate for a middle ear infection. The OtoNexus device resembles an otoscope in shape and usage to fit seamlessly into the pediatricians’ current routine with no learning curve, additional steps, or interpretation necessary. It provides actionable quantitative data that is not available today with any other technology or tool. The use of this data significantly improves patient care while adhering to the American Academy of Pediatrics Guidelines. The data can also be shared with parents to enhance their understanding of the treatment plan for their child.
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info